CC
ELV icon

Clearline Capital’s Elevance Health ELV Stock Holding History

Clearline Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,919
Closed -$1.38M – 129
2023
Q4 		$1.38M Sell
2,919
-7,928
-73% -$3.67M 0.15% 78
2023
Q3 		$4.72M Hold
10,847
– – 0.47% 63
2023
Q2 		$4.82M Sell
10,847
-4,486
-29% -$2.07M 0.62% 47
2023
Q1 		$7.05M Buy
+15,333
New +$7.3M 1.06% 33
2016
Q4 		– Sell
-13,248
Closed -$1.66M – 52
2016
Q3 		$1.66M Buy
+13,248
New +$1.71M 0.52% 38

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return